baber/WOPTO huggingface dataset:
Patent AU-625970-B2 (AU)
Title: Hiv-3 retrovirus and its use
Inventor: LEYS ROBERT DE
IPC: C12N15/09
Filed: 1989-06-08
Granted: 1992-07-23
Abstract: Described are new HIV-3 retrovirus strains comprising in their nucleic acid sequence a contiguous R region and an U3 region sequence showing a homology of more than 70% with the nucleic acid sequence as represented in SEQ ID NO 3, and provided that said HIV-3 retrovirus strains have at least one nucleotide difference in their sequence compared to the HIV-3 (ANT 70) retrovirus strain deposited under ECACC N° V88060301. Further described are antigens obtained from the virus, particularly proteins p12, p16, p25 and glycoproteins gp41 and gp120 to be used in the diagnosis of ARC or AIDS caused by HIV-3. Immunogenic compositions to be used as vaccines contain an envelope glycoprotein of HIV-3 such as gp41 or gp120.
Patent AU-670782-B2 (AU)
Title: High strength steel sway bars and method of making
Inventor: GALLAGHER HUGH M JR
IPC: F16F1/14
Filed: 1993-03-09
Granted: 1996-08-01
Abstract: Sway bars Ä10Ü made of high strength steel having grains Ä15Ü with a preferred orientation, and methods of making such sway bars Ä10Ü from blanks of high strength steel typically having a yield strength of at least about 90,000 psi and a tensile strength of at least about 120,000 psi.
Patent AU-667119-B2 (AU)
Title: Fermented sour doughs
Inventor: BUENSOW RUDOLF
IPC: A21D8/04
Filed: 1993-06-29
Granted: 1996-03-07
Abstract: The invention concerns fermented sour doughs, comprising starter material, ground cereal kernels or grains, balance water that contain maximum 32 wt % of water and display a pH <4.2. The titratable acidity of the doughs is at least 25, the weight ratio lactic acid: acetic acid of the doughs is <3.0. The doughs can contain salt and can be mixed with a pre-dried flour with water content 1-5 wt %. Part of the invention is also a process for the preparation of the fermented sour doughs.
Patent AU-577147-B2 (AU)
Title: Drink dispenser with compatible components
Inventor: SEDAM JASON K
IPC: B67D1/08
Filed: 1985-08-30
Granted: 1988-09-15
Abstract: A beverage dispenser including a concentrate supply compartment (15) for supporting concentrate containers (12) in dispensing positions, an access door (11) to the compartment and protrusions (18) on the inside of the access door which fit into recesses in the containers when the door is closed. The door also must actuate a limit switch (24) when the door is closed before the dispenser can be electrically energized to dispense a selected beverage.
Patent AU-755993-B2 (AU)
Title: Processes to generate submicron particles of water-insoluble compounds
Inventor: PACE GARY W
IPC: B01J3/00
Filed: 1999-06-18
Granted: 2003-01-02
Abstract: Submicron particles of water-insoluble compounds, particularly drugs, are prepared by simultaneously stabilizing microparticulate suspensions of same with surface modifier molecules by rapid expansion into an aqueous medium from a compressed solution of the compound and surface modifiers in a liquefied gas and optionally homogenizing the aqueous suspension thus formed with a high pressure homogenizer.
Patent AU-621178-B2 (AU)
Title: Plant protective microemulsion composition
Inventor: SZEKELY ISTVAN
IPC: A01N53/00
Filed: 1989-12-21
Granted: 1992-03-05
Abstract: PCT No. PCT/HU89/00065 Sec. 371 Date Jul. 24, 1990 Sec. 102(e) Date Jul. 24, 1990 PCT Filed Dec. 21, 1989 PCT Pub. No. WO90/06681 PCT Pub. Date Jun. 28, 1990.A solution of a plant protective agent is disclosed, which comprises per liter of solution 1 to 150 g/l of one or more synthetic pyrethroid(s) as active ingredient(s) and 40 to 70 g/l of ethoxylated (EO=10 to 14)-propoxylated (PO)=18 to 22) nonylphenol, 10 to 20 g/l of linear calcium dodecylbenzenesulfonate, 90 to 120 g/l of polyoxyethylene(20)-sorbitan monolaurate as the surface active agents, and a solvent mixture (A) consisting of 9 to 11% by volume of hydrogenated aliphatic hydrocarbon containing 45% of naphthene, 18 to 30% by volume of propylene glycol, 28 to 35% by volume of pine fatty acid, 23 to 30% by volume of sunflower oil, 5 to 10% by volume of an 1:1 by volume mixture of methanol or ethanol with isobutanol in an amount to complete the volume to 1 liter.
Patent AU-624219-B2 (AU)
Title: Process for preparation of aluminoxane
Inventor: MAEZAWA HIROSHI
IPC: C08F10/00
Filed: 1990-02-08
Granted: 1992-06-04
Abstract: The present invention relates to a process for preparing aluminoxane which comprises reacting an organoaluminum compound and water in a solvent system containing solvent having a higher boiling point than that of the organoaluminum compound, and condensing the resulting reaction mixture under atmospheric pressure or reduced pressure. The present invention further relates to a process for preparing aluminoxane which comprises reacting an organoaluminum compound and water, adding a solvent system containing solvent having a higher boiling point than that of the organoaluminum compound to the above obtained reaction mixture, and condensing the resulting solution under atmospheric pressure or reduced pressure. In accordance with the process of the present invention, high purity and high activity aluminoxane can be produced in a simplified manner.   Moreover, a solution of high purity aluminoxane obtained by the process of the present invention can be used as such as a catalyst component for production of olefin-based polymers and styrene-based polymers and thus it does not need a step of dissolving or preparing a slurry.
Patent AU-665643-B2 (AU)
Title: An apparatus for discharging packaging container blanks
Inventor: ANDERSSON ROLAND
IPC: B65H3/08
Filed: 1993-12-20
Granted: 1996-01-11
Abstract: In terms of their operational reliability, apparatuses for discharging from a magazine of flat-laid packaging container blanks of the type used for manufacturing packaging containers for liquid contents are greatly dependent upon the quality of the packaging container blanks themselves. In the event of varying friction or abutment pressure between the packaging container blanks, there is a risk that more than one blank is discharged at a time, or alternatively that no blank is discharged at all. In order to ensure a dependable function with repeated discharge of one blank at a time and at a predetermined rate, the apparatus according to the present invention includes a pivotal lever (9) provided with a suction cup or cups (11), the lever displacing one packaging container blank (5) at a time from the discharge end of a magazine past a segmented wheel which grasps the discharged blank (5) between a rubber cladding (15) and a counter wheel (13) for further advancement to a conveyor (21). <IMAGE>
Patent AU-624951-B2 (AU)
Title: New sulfonamides derived from benzocyclic or benzoheterocyclic acids, their preparation and application in thereapeutics
Inventor: BIGG DENNIS
IPC: A61K31/19
Filed: 1990-04-04
Granted: 1992-06-25
Abstract: The invention relates to new sulfonamides derived from benzocyclic or benzoheterocyclics and their derivatives of general formula (I), in which R represents a light alkyl radical of 1 to 9 C, linear or branched; a phenyl radical substituted or not by one or several groups: a light alkyl branched or not, having 1 to 4 C, halogeno, alkyloxy, nitro, amino, dialkylamino, CF3; a naphthalene substituted or not; a thiophenyl radical; R1 represents a lower alkyl branched or not, a benzyl; R2 represents a hydrogen, a lower alkyl group branched or not. A phenyl group substituted or not, an arylalkyl group; R3 represents a hydrogen or a lower alkyl, branched or not (1 to 6 C); X represents a divalent fonctional radical chosen from the following : -CH2-; -CH-OR4; -C=O; -C=N-OR4; and  alpha  with R4=H or Me, with -X- where X is different from -CH2- when -A- represents divalent radicals a, b, d, and e below. -A- represents a benzocyclic or benzoheterocyclic bivalent radical chosen from the compounds (a) to (j); n can take the values of 1 to 4 inclusive; as well as the therapeutically acceptable, organic or mineral salts  (R3=H), the pure isomers or diastereoisomers or their mixture and all the pharmaceutical compositions of formula (I) with other active principles. Said invention relates to the application of (I) as medication and to the preparation processes.
Patent AU-544771-B2 (AU)
Title: Production of monoclenal antibody to human t-cells
Inventor: KUNG PATRICK CHUNG-SHU
IPC: G01N33/50
Filed: 1980-03-19
Granted: 1985-06-13
Abstract: Hybrid cell line for production of monoclonal antibody to an antigen found on all normal human T cells. The hybrid is formed by fusing splenocytes from immunized Balb/cJ mice with P3X63Ag8UI myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
Patent AU-695807-B2 (AU)
Title: Quick connector
Inventor: BARTHOLOMEW DONALD DEKLE
IPC: F16L11/04
Filed: 1993-11-16
Granted: 1998-08-20
Abstract: In its preferred embodiment, a quick connector (10) for connecting a male conduit (12) to a female receptacle (14) has a pair of waist segments (60 and 62), a body segment (56), and a pair of leg segments (68). Each of the leg segments (68) are defined by a pair of projecting elements (76) which are at least partially compressible toward one another thereby causing the pair of waist segments (60 and 62) to move toward one another. A confirmer ring (114) is provided on the pair of projecting elements (76). Confirmation that the quick connector (10) is properly locked in place is made when the confirmer ring (114) is fully seated within a portion of the opening (18) of female receptacle (14). An alternate embodiment provides for use of the confirmer ring (114) as an installing tool when connecting the male conduit (12) with the female receptacle (14). An additional alternate embodiment allows usage of the confirmer ring (114) as a tool for installation and decoupling of the male conduit (12) into the female receptacle (14), as well as for confirming the connection.
Patent AU-635058-B2 (AU)
Title: Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same
IPC: C12P21/08
Filed: 1990-06-28
Granted: 1993-03-11
Abstract: Mammalian genes and proteins, designated cytokine synthesis inhibitory factors (CSIFs), are provided which are capable of inhibiting the synthesis of cytokines associated with delayed type hypersensitivity responses, and which, together with antagonists, are useful in treating diseases associated with cytokine imbalances, such as leishmaniasis and other parasitic infections, and certain immune disorders including MHC associated autoimmune diseases caused by excessive production of interferon- gamma .
Patent AU-771122-B2 (AU)
Title: Detection article having fluid control film with capillary channels
Inventor: JOHNSTON RAYMOND P
IPC: G01N30/60
Filed: 2000-07-07
Granted: 2004-03-11
Abstract: A detection article including at least one fluid control film layer having at least one microstructured major surface with a plurality of microchannels therein. The microchannels configured for uninterrupted fluid flow of a fluid sample throughout the article. The film layer including an acquisition zone wherein portions of the plurality of microchannels draw the fluid sample into the plurality of microchannels through openings in the microchannels at least by spontaneous fluid transport. The film layer also including a detection zone in uninterrupted fluid communication with the acquisition zone along the microchannels with the detection zone including at least one detection element that facilitates detection of a characteristic of the fluid sample within at least one microchannel of the detection zone. The detection article may be formed from a plurality of film layers that are stacked to form a three-dimensional article. The detection zone may include a plurality of detection elements, which may be all the same, may be all different or may have some different and some the same. In addition, the detection elements may be variations of the same element. The detection elements may include hardware devices, assay reagents and/or sample purification materials.
Patent AU-587846-B2 (AU)
Title: Method of making low loss fiber optic coupler
Inventor: KECK DONALD BRUCE
IPC: G02B6/26
Filed: 1986-08-08
Granted: 1989-08-31
Abstract: A low loss fiber optic coupler is fabricated by forming a coupler preform (10) having a plurality of spaced glass cores (12,13) extending longitudinally through a matrix of glass having a refractive index lower than that of the cores. The preform is heated and stretched to form a glass rod (20) which is then severed into a plurality of units (21). Heat is applied to the central region (23) of each unit while the ends of the unit are pulled apart to elongate the taper inwardly the heated central region. The unit is then provided with a plurality of optical fibers (69, 70, 75, 76°, 82, 83; 89), one of which extends from each of the cores at the endfaces of the unit. A preferred method of providing the optical fibers involves forming the coupler preform of a matrix glass (46) that is easily dissolves in a solvent. Each of the fiber cores within the matrix is surrounded by a layer of cladding glass (54) that is relatively resistant to disolving by the solvent.
Patent AU-684429-B2 (AU)
Title: Electrotransport system
Inventor: LATTIN GARY A
IPC: A61N1/32
Filed: 1996-08-07
Granted: 1997-12-11
Abstract: A device for the electrically assisted delivery of a therapeutic agent is described. The device (500) comprises one or more rigid zones. The skin side of the rigid zone has a radius of curvature (520) which approximates that of the body site to which the device (500) is to be attached. <IMAGE>
Patent AU-670866-B2 (AU)
Title: Phosphonomethyldipeptides
Inventor: ORCHYMONT HUGUES D
IPC: A61P11/00
Filed: 1994-02-22
Granted: 1996-08-01
Abstract: Dipeptides and analogs thereof having a phosphonomethyl moiety attached thereto which inhibit Endothelin Converting Enzyme and are thus useful in treating conditions responsive thereto.
Patent AU-584765-B2 (AU)
Title: Copolymer of acrylamide and dimethylaminopropylacrylamide as flocculating agents and process for dewatering sludge by use of these flocculating agents.
Inventor: HARTAN HANS-GEORG DR DIPL CHEM
IPC: C08F220/56
Filed: 1986-12-16
Granted: 1989-06-01
Abstract: The copolymers are used as flocculants in the dewatering of sewage sludges produced on mechanically biological purification of communal industrial effluents.
Patent AU-729063-B2 (AU)
Title: Self-regulated apoptosis of inflammatory cells by gene therapy
Inventor: TATAKE REVATI J
IPC: A61P17/06
Filed: 1998-02-27
Granted: 2001-01-25
Abstract: This invention relates to the therapeutic induction of apoptosis in activated inflammatory cells, or cells at a site of inflammation, by introducing into those cells a chimeric gene containing an apoptosis-inducing gene (AIG) driven by a promoter of an inducible gene activated in inflammation and a promoter enhancer such that the inflammatory cells are targeted. In one embodiment, the chimeric gene comprises at least one TNFalpha promoter enhancer attached to a functional copy of a minimal TNFalpha promoter and further attached to at least one copy of an apoptosis-inducing gene, wherein expression of the gene is driven by the TNFalpha promoter. Attachment can be direct, distal, proximal or combinations thereof. Example apoptosis-inducing genes include caspase 3, caspase 4, caspase 5, Granzyme B. Advantageously, the TNFp-AIG chimeric gene is expressed in only those cells producing the inflammatory cytokine, TNFalpha. In addition, the TNFp-AIG chimeric gene also sequesters inducible TNFp transcription factors, thereby reducing endogenous production of TNFalpha. The invention also relates to methods of making and using self-regulated apoptosis chimeric genes and pharmaceutical compositions containing them for treating inflammatory diseases.
Patent AU-677066-B2 (AU)
Title: Orthopedic casting tape
Inventor: GREEN RICHARD
IPC: A61L15/07
Filed: 1994-05-04
Granted: 1997-04-10
Abstract: The invention is directed to orthopedic casting tapes including the combination of a knit tape and a hardenable liquid resin coated onto the knit tape. The knit tape includes alternating thick and thin portions extending transversely across the tape. Such casting tapes have been found to be capable of improving cast strength.
Patent AU-590060-B2 (AU)
Title: Topical antibacterial/antifungal composition comprising a silver compound and an azole compound
Inventor: EDWARDS LINDA MARY
IPC: A61K33/38
Filed: 1987-03-23
Granted: 1989-10-26
Abstract: Pharmaceutical compositions which are suitable for topical application in the treatment of bacterial and/or fungal infections are described. The compositions comprise a synergistic mixture of a silver compound and an azole derivative together with a pharmaceutically acceptable carrier therefor. The compositions may be applied topically in the treatment of burns ulcers and other skin lesions, general skin infections and also in the treatment of infections of the mucous membranes. Preferred compositions contain silver sulphadiazine and clotrimazole or metronidazole. The compositions may be applied as ointments, gels, pessaries, tablets and the like.
Patent AU-679763-B2 (AU)
Title: Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents
Inventor: SABOL JEFFREY S
IPC: C07D473/34
Filed: 1994-05-31
Granted: 1997-07-10
Abstract: The present invention is directed to a class of novel carbocyclic derivatives having formulas (I) and (II) and their use as anti-viral and anti-neoplastic agents, wherein X1 and X2 are each independently hydrogen, fluorine, or chlorine, R is hydrogen or hydroxymethyl, J is a radical of formulas (a), (b) and (c). Y1 is a CH group, a CCl group, a CBr group or a CNH2 group, Y2 and Y3 are each independently nitrogen or a CH group, Y1 is a CH group, a CCl group, a CBr group or a CNH2 group, Y2 and Y3 are each independently nitrogen or a CH group, Y4 is hydrogen, C1-C4 alkyl, C1-C4 alkoxy or halogen, Y5 is NH2 or C1-C4 alkoxy, Q is NH2, NHOH, NHCH3, OH, or hydrogen, and V is hydrogen, halogen or NH2; or a pharmaceutically acceptable salt thereof.
Patent AU-776125-B2 (AU)
Title: New linear or cyclic ureas, a process for their preparation and pharmaceutical compositions containing them
Inventor: PEGLION JEAN-LOUIS
IPC: C07D211/00
Filed: 2000-12-29
Granted: 2004-08-26
Abstract: Piperidinyl- or piperazinyl-substituted linear or cyclic urea derivatives (or analogs) (I) are new. Piperidine or piperazine derivatives of formula (I) and their isomers, hydrates, solvates and acid addition salts are new. [Image] V, M : direct bond or linear or branched 1-6C alkylene; A, E : N or CH, provided that at least one is N; W : diaza-cyclic group of formula (a) or bicyclic group of formula (b), or may also be a bicyclic group of formula (c) if V = direct bond and A = N; [Image] * : attachment point; X : CO, SO or SO 2; G 12-4C n-alkylene (optionally containing a double bond and/or substituted by OH); G 2direct bond; and G 32-3C n-alkylene (optionally containing a double bond); or G 2CH 2; and G 31-2C n-alkylene (optionally containing a double bond); T : fused benzene or pyridine ring; R 1H, alkyl, Ar or Ar-alkyl; R 2 a, R 2 bH, halo, alkyl, OH, alkoxy, SH, alkylthio, trihaloalkyl, CN, NO 2, NH 2, mono- or dialkylamino, trihaloalkoxy, Ar-alkoxy, alkylsulfonate, trihaloalkylsulfonate or alkylsulfonyl; or R 2 a + R 2 bOCH 2O, O(CH 2) 2O, O(CH 2) 3O or CH 2CH 2 (optionally substituted by CN, CH 2OH, alkoxycarbonyl, ArOCO, or Ar-alkoxycarbonyl); R 3Ar or Het 1 (both optionally substituted by one or more R 2 a); Y : OAr, OHet 1 or Het 2 (all optionally substituted by one or more R 2 a); Ar : phenyl, biphenyl, naphthyl, dihydronaphthyl, tetrahydronaphthyl, indanyl, indenyl or benzocyclobutyl; Het 15-12 membered mono- or bicyclic aromatic system containing 1 or 2 of O, S and N as heteroatom(s), where in the case of bicyclic systems one of the rings may be partially hydrogenated; and Het 25-12 membered mono- or bicyclic aromatic system containing 1-3 of O, S and N as heteroatom(s). alkyl moieties have 1-6C unless specified otherwise; provided that: (i) if V = direct bond, W = (a) and R 3 = Ph, then Y cannot be 3-indolyl; (ii) if M = direct bond, W = (a) and Y = bicyclic Het 2 in which one ring is a benzene ring, then Y cannot be bonded to M via this benzene ring; and (iii) if M = direct bond, V = CH 2CH 2, W = (a) and R 3 = Ph, then Y cannot be 1,2-benzisoxazol-3-yl. An independent claim is included for the preparation of (I). ACTIVITY : Vasotropic; antiarteriosclerotic; cardiant; hypotensive. MECHANISM OF ACTION : Endothelial nitrogen monoxide (NO) synthase inhibitor antagonist; superoxide antagonist; antioxidant. (I) reduce endothelial dysfunction and reduction in vascular NO availability induced by inhibition of endothelial NO synthase or by oxidative stress associated with production of superoxide anion. In tests in rat aortic rings, N-(2-(4-(phenoxymethyl)-1-piperidinyl)-ethyl)-1-indoline-carboxamide (Ia) at a concentration of 30 nM gave 26 % inhibition of endothelial dysfunction induced by the NO synthase inhibitor N(G)-nitro-L-arginine.
Patent AU-640207-B2 (AU)
Title: Process and composition for the treating of injuries caused by the radiation of heat and light
IPC: A61P37/00
Filed: 1991-02-28
Granted: 1993-08-19
Abstract: The invention relates to a process for the preparation of medicines, medical cosmetics or cosmetical products containing as active ingredient  gamma -L-glutamyl taurine of formula (I) which comprises admixing a compound of formula (I) with pharmaceutically and/or cosmetically acceptable inert, non-toxic carriers and/or additives, and preparing a composition suitable for the prevention and/or treating of skin injuries and/or autoimmune diseases caused by the radiation of heat and light.
Patent AU-647101-B2 (AU)
Title: Salts of 1,3,4,6,7,8-hexahydro-2H-pyrimido-(1,2-a)-pyrimide (HHPP)
Inventor: DAHLGREN ATTI-LA
IPC: A61P35/00
Filed: 1991-03-13
Granted: 1994-03-17
Abstract: Novel pharmaceutically active compounds which can be formed from 1,3,4,6,7,8-hexahydro-2H-pyrimido-(1,2-a)-pyrimidine (HHPP) or an 1-alkyl (R) derivative thereof, wherein R is hydrogen or an alkyl group, preferably -CH3?, and a residue of an acid or acid anhydride of classes comprising specific acids and acid anhydrides of an acid HA or H2?A selected from indole carboxylic acid, preferably from 2-indole carboxylic acid, 2,4,6-trihydroxy benzaldehyde being made subject to oxidation, 3-nitro-o-toluic acid, phthalic anhydride and benzoic anhydride, or an ester or acid chloride thereof; the acid being further selected from 4-chloro-2-nitrobenzoic acid, 4-nitrophenylacetic acid, 2,4-dinitrophenylacetic acid, 5-chloro-2-nitrobenzoic acid, 4-chloro-3-nitrobenzoic acid, 5-nitrosalicylic acid, (2-hydroxy-5-nitrobenzoic acid), 3-hydroxy-4-nitrobenzoic acid, 2-iodobenzoic acid, 5-amino-5-hydroxybenzoic acid, 5-nitroisophthalic acid, (5-nitrobenzene-1, 3-dicarboxylic acid); an amino acid, such as a natural amino acid, such as selected from glycine, L-glutamine and L-histidine, and further such as an amino acid selected from L-valine, L-leucine, and 4-aminobutyric acid (GABA), L-glutamic acid, L-serine, L-lysine, L-proline, L-alanine, L-cysteine, L-4-hydroxyvaline, L-aspartic acid, L-phenylalanine, L-tryptophane, and L-methionine; boric acid; or a neutral amine salt of such a pharmaceutically active compound. The compounds have antiviral activity.
Patent AU-699661-B2 (AU)
Title: Fractionation of triglyceride oils
Inventor: KOMMER MARCELLE VAN DEN
IPC: C11B7/00
Filed: 1994-07-15
Granted: 1998-12-10
Abstract: Process for triglyceride oil fractionation using a crystallisation modifying substance which is a copolymer having subunits A and B of which subunit A is derived from maleic acid or itaconic acid and subunit B is derived from vinyl alcohol, alkyl substituted vinyl alcohol, acrylic acid or styrene, A and B being present in a ratio of 10:1 to 1:10, where 5-100% of the the maleic acid or itaconic acid subunits are connected to unbranched (C8-C24)-alkyl chains and where 0-100% of the vinyl alcohol or alkyl substituted vinyl alcohol or acrylic acid subunits are connected to unbranched (C1-C8)-alkyl chains.